These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT). Sparber-Sauer M; Ferrari A; Spunt SL; Vokuhl C; Casey D; Lautz TB; Meyer WH; Walterhouse DO; Pajtler KW; Alaggio R; Schmidt A; Safwat A; Timmermann B; Dall'Igna P; Chen S; Weiss AR; Orbach D Cancer Med; 2023 May; 12(10):11719-11730. PubMed ID: 36744538 [TBL] [Abstract][Full Text] [Related]
25. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843 [TBL] [Abstract][Full Text] [Related]
26. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382 [TBL] [Abstract][Full Text] [Related]
27. Histology and fusion status in rhabdomyosarcoma. Rudzinski ER Am Soc Clin Oncol Educ Book; 2013; ():425-8. PubMed ID: 23714565 [TBL] [Abstract][Full Text] [Related]
29. Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Stegmaier S; Sparber-Sauer M; Aakcha-Rudel E; Münch P; Reeh T; Feuchtgruber S; Hallmen E; Blattmann C; Bielack S; Klingebiel T; Koscielniak E Pediatr Blood Cancer; 2022 Sep; 69(9):e29652. PubMed ID: 35338758 [TBL] [Abstract][Full Text] [Related]
30. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125 [TBL] [Abstract][Full Text] [Related]
31. Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group. Milewski D; Jung H; Brown GT; Liu Y; Somerville B; Lisle C; Ladanyi M; Rudzinski ER; Choo-Wosoba H; Barkauskas DA; Lo T; Hall D; Linardic CM; Wei JS; Chou HC; Skapek SX; Venkatramani R; Bode PK; Steinberg SM; Zaki G; Kuznetsov IB; Hawkins DS; Shern JF; Collins J; Khan J Clin Cancer Res; 2023 Jan; 29(2):364-378. PubMed ID: 36346688 [TBL] [Abstract][Full Text] [Related]
32. Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults. Sparber-Sauer M; Ferrari A; Kosztyla D; Ladenstein R; Cecchetto G; Kazanowska B; Scarzello G; Ljungman G; Milano GM; Niggli F; Alaggio R; Vokuhl C; Casanova M; Klingebiel T; Zin A; Koscielniak E; Bisogno G Pediatr Blood Cancer; 2022 Sep; 69(9):e29691. PubMed ID: 35441463 [TBL] [Abstract][Full Text] [Related]
33. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326 [TBL] [Abstract][Full Text] [Related]
34. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome. Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110 [TBL] [Abstract][Full Text] [Related]
35. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574 [TBL] [Abstract][Full Text] [Related]
36. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643 [TBL] [Abstract][Full Text] [Related]
37. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma. Harel M; Ferrer FA; Shapiro LH; Makari JH Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985 [TBL] [Abstract][Full Text] [Related]
38. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study. Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861 [TBL] [Abstract][Full Text] [Related]
39. Biological Role and Clinical Implications of Di Carlo D; Chisholm J; Kelsey A; Alaggio R; Bisogno G; Minard-Colin V; Jenney M; Dávila Fajardo R; Merks JHM; Shipley JM; Selfe JL Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980529 [TBL] [Abstract][Full Text] [Related]
40. Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram. De Salvo GL; Del Bianco P; Minard-Colin V; Chisholm J; Jenney M; Guillen G; Devalck C; Van Rijn R; Shipley J; Orbach D; Kelsey A; Rogers T; Guerin F; Scarzello G; Ferrari A; Cesen Mazic M; Merks JHM; Bisogno G; Cancer; 2024 Jul; 130(13):2351-2360. PubMed ID: 38400828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]